Jason M. Pogue

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

Brian T. Tsuji, Jason M. Pogue, Alexandre Prehn Zavascki et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2019 · 931 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19

Emily C. Somers, Gregory Eschenauer, Jonathan P. Troost et al. · Clinical Infectious Diseases · 2020 · 501 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial

Richard G. Wunderink, Yuko Matsunaga, Mari Ariyasu et al. · The Lancet Infectious Diseases · 2020 · 464 citations

Pharmacy, Clinical Sciences, Infectious Diseases +17

Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health System

Jason M. Pogue, Jaewon Lee, Dror Marchaim et al. · Clinical Infectious Diseases · 2011 · 331 citations · Full text

Medicine, Infectious Diseases, Nephrology +15

A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity

Natalie A. Finch, Evan J Zasowski, Kyle P. Murray et al. · Antimicrobial Agents and Chemotherapy · 2017 · 235 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17